ADVERSE DRUG REACTIONS (ADRs) DETECTION AND REPORTING IN INDIA: CURRENT STATUS, CHALLENGES, AND FUTURE PERSPECTIVES
EPRA International Journal of Research & Development (IJRD) · 20.03.2026 · 310
DOI: 10.36713/epra26594 ↗Kurz gefasst
Fachartikel in der Zeitschrift EPRA International Journal of Research & Development (IJRD), online erschienen am 20.03.2026. Verfasst von Abhishek Sharma und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Adverse Drug Reactions (ADRs) are a major concern in clinical practice and significantly contribute to morbidity and mortality worldwide [1]. Pharmacovigilance plays a crucial role in detecting, assessing, and preventing ADRs [2]. In India, the Pharmacovigilance Programme of India (PvPI) has been established to monitor drug safety [3]. However, underreporting remains a major challenge due to lack of awareness and inadequate training [4].
Zitieren
APA
Sharma, A., Sharma, D., & Gupta, A. (2026). ADVERSE DRUG REACTIONS (ADRs) DETECTION AND REPORTING IN INDIA: CURRENT STATUS, CHALLENGES, AND FUTURE PERSPECTIVES. EPRA International Journal of Research & Development (IJRD), 310. https://doi.org/10.36713/epra26594
Vancouver
Sharma A, Sharma D, Gupta A. ADVERSE DRUG REACTIONS (ADRs) DETECTION AND REPORTING IN INDIA: CURRENT STATUS, CHALLENGES, AND FUTURE PERSPECTIVES. EPRA International Journal of Research & Development (IJRD). 2026:310. doi:10.36713/epra26594
BibTeX
@article{Sharma2026,
author = {Sharma, Abhishek and Sharma, Deepali and Gupta, Ayush},
title = {ADVERSE DRUG REACTIONS (ADRs) DETECTION AND REPORTING IN INDIA: CURRENT STATUS, CHALLENGES, AND FUTURE PERSPECTIVES},
journal = {EPRA International Journal of Research & Development (IJRD)},
year = {2026},
pages = {310},
doi = {10.36713/epra26594}
}
EUVIMED